Comparison of the ID NOW and Accula Point-of-Care Assays for Detection of COVID-19

Withdrawn before enrolling

Conditions studied: Covid-19

In brief

This study is a comparison of the ID Now COVID-19 (Abbott) assay to the Accula SARS-CoV-2 (Mesa Biotech) assay to assist in the identification of infection with COVID-19. The tests will be compared for sensitivity, specificity, positive predictive value and negative predictive value.

Key facts

Study ID

NCT04403035

Run by

Henry Ford Health System

People needed

0

Starts

2020-05-10

Expected to finish

2021-05-09

Last updated by the study team

2021-07-23

Who can join

Age: 18 and older, up to 95. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Covid-19 testing has been ordered in the Emergency Dept. or for inpatients in the hospital or patient has already tested positive via PCR.
• Adult patients
• Consent obtained

You may not qualify if…

• Testing not ordered or tested negative via PCR.
• Children
• Do not consent

Where it is running

• Ascension St. John Hospital — Detroit, Michigan, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.